课题基金 / 基金详情

Expression and function of the TLRs on T cells

Expression and function of the TLRs on T cells
T 细胞上 TLR 的表达和功能
批准号:
7273901
负责人:
Laurence A Turka
金额:
$1.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-01-01 至 2010-12-31

项目摘要

项目成果

Laurence A Turka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Toll-like receptors (TLRs) are highly conserved proteins which play an integral role in innate and adaptive immunity. The nine characterized mammalian TLRs are pattern recognition receptors for integral pathogen associated molecular patterns (PAMPs), providing a means to discriminate between self and non-self. Ligation of TLRs activates cells of the innate immune system, inducing functions such as phagocytosis and IFN-a and IFN-b secretion. TLR-ligation also serves as a bridge between the innate and adaptive immune systems. TLR stimulation of DCs and macrophages induces the production of inflammatory cytokines such as IL-12, and upregulation of MHC class II and costimulatory ligands such as CD40 and CD86. While roles if or TLRs on APCs are well-established, surprisingly little is known about their expression and potential function on T cells. New studies from our laboratory show that several TLRs are expressed following activation of na?ve CD4+CD25- T cells. Ligation of these TLRs by their appropriate PAMPs activates several known downstream signaling pathways, including NF-kB, p38 JNK, and ERK. Functionally, this leads to enhanced T cell survival and may also provide costimulation with sub-optimal TCR ligation. Our workinq hypothesis is that TLRs signaling on T cells is an important contributor to cellular immune responses, and a block to the development of tolerance. To this end, the long-term goals of this research program are to define the expression and function of TLRs on T cells. In specific aim #1 we will characterize the signals which govern the expression and upregulation of TLRs on T cells, and the downstream signaling pathways which TLRs use to mediate their effects. Specific aim #2 will use cells from TCR transgenic mice coupled with in vitro and in vivo adoptive transfer systems to conduct a detailed examination of the effects of TLR activation of T cells on induction of activation and costimulatory molecules, cytokine production or skewing, and effector/memory differentiation and responsiveness. This approach will allow for precise definition of what TLR stimulation of T cells can do. In specific aim #3 we will then ask which if the functions identified for TLRs in aim #2 are operative during in vivo immune responses. To do so, we will create in vivo models in which only T cells are deficient in TLR signaling, in order to assess the specific role of TLR signals on T cells during in vivo immune responses. Specific models include adoptive transfers, bone-marrow chimeras, and transplantation using TCR transgenic mice on TLR3- or MyD88-deficient backgrounds
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of Treg Homeostasis and Function by the Lipid Phosphatase PTEN
  • 批准号:
    8722954
  • 项目类别:
  • 资助金额:
    $19.83万
  • 财政年份:
    2013
  • 负责人:
    Laurence A Turka
  • 依托单位:
Control of Treg Homeostasis and Function by the Lipid Phosphatase PTEN
  • 批准号:
    8489869
  • 项目类别:
  • 资助金额:
    $24.86万
  • 财政年份:
    2013
  • 负责人:
    Laurence A Turka
  • 依托单位:
The Control of T Cell Development in Responses by PTEN
Administrative Core
  • 批准号:
    7694143
  • 项目类别:
  • 资助金额:
    $8.7万
  • 财政年份:
    2008
  • 负责人:
    Laurence A Turka
  • 依托单位:
国内基金
海外基金
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
  • 批准号:
    82371651
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵栋
  • 依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
  • 批准号:
    82370798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王晓
  • 依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
  • 批准号:
    82371373
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    沃雁
  • 依托单位: